Investigator

Takahiro Kogawa

Japanese Foundation For Cancer Research, Department of Advanced Medical Development

TKTakahiro Kogawa
Papers(1)
HERTHENA-PanTumor01: …
Collaborators(10)
Thomas PowlesTomohiro NishinaAarti BhatiaAriel E. AguiloBarbara BurtnessChristos FountzilasDani R. CastilloFan JinFunda Meric-BernstamGraham Clinthorne
Institutions(9)
Cancer Institute Of N…Queen Mary University…National Hospital Org…Yale Cancer CenterDaiichi Sankyo Portug…Roswell Park Comprehe…City Of Hope National…MerckThe University Of Tex…

Papers

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

Clinical Trials (1)

NCT06172478Daiichi Sankyo

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. The study is enrolling cohorts of participants with melanoma \[cutaneous/acral\], squamous cell carcinomas of the head and neck (SCCHN), HER2-negative gastric cancer ovarian carcinoma, cervical cancer, endometrial cancer, bladder cancer, esophageal carcinoma, pancreatic carcinoma, prostate cancer, second-line gastric cancer, lung cancer, and breast cancer.

1Papers
16Collaborators
1Trials
Triple Negative Breast NeoplasmsNeoplasmsDrug Resistance, NeoplasmCell Line, TumorXenograft Model Antitumor AssaysInflammatory Breast NeoplasmsApoptosis

Positions

2020–

Researcher

Japanese Foundation For Cancer Research · Department of Advanced Medical Development

Links & IDs
0000-0003-3730-6591